COMMUNIQUÉS West-GlobeNewswire

Genmab to Present at the Jefferies 2017 London Healthcare Conference

07/11/2017 - 14:56

Media Release Copenhagen, Denmark; November 7, 2017 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that the company’s CEO, Jan van de Winkel, Ph.D., will present an update at the Jefferies 2017 London Healthcare [...]

UPDATE -- Tabula Rasa HealthCare Announces Third Quarter 2017 Results and Revised Financial Outlook

07/11/2017 - 14:52

MOORESTOWN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a healthcare technology company optimizing medication safety by deploying new medication risk mitigation digital [...]

Zealand Pharma will attend the Jefferies Healthcare Conference in London and the Bryan Garnier & Co Healthcare Conference in Paris, both in November

07/11/2017 - 14:48

Press release - No. 10 / 2017 Zealand Pharma will attend the Jefferies Healthcare Conference in London and the Bryan Garnier & Co Healthcare Conference in Paris, both in November Copenhagen, November 7, 2017 - Mats [...]

Ultragenyx Completes Tender Offer and Acquisition of Dimension Therapeutics

07/11/2017 - 14:43

NOVATO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE ) ("Ultragenyx" or the "Company"), a biopharmaceutical company focused on the development of novel products for rare and [...]

Sarepta Therapeutics Announces FDA Clearance of IND for the Company’s PPMO Exon 51 Candidate, SRP-5051

07/11/2017 - 14:30

CAMBRIDGE, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT ), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicine to [...]

Fortress Biotech Announces Pricing of Series A Preferred Stock Offering

07/11/2017 - 14:30

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Fortress Biotech, Inc. (Nasdaq: FBIO ) (“Fortress”), a biopharmaceutical company dedicated to acquiring, developing and commercializing novel pharmaceutical and biotechnology [...]

Collegium Receives FDA Approval for sNDA for Xtampza® ER

07/11/2017 - 14:30

CANTON, Mass., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL ) announced today that the U.S. Food and Drug Administration (FDA) approved its Supplemental New Drug Application (sNDA) to [...]

Cellectar Announces Updated Median Overall Survival of 26.2 Months from Cohort 1 of CLR 131 Phase 1 Trial in Advanced Multiple Myeloma

07/11/2017 - 14:30

MADISON, Wis., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB ), an oncology-focused, clinical stage biotechnology company (the “company”), today announces that the ongoing median overall [...]

Evoke Pharma Schedules Conference Call and Webcast for Third Quarter 2017 Financial Results

07/11/2017 - 14:30

SOLANA BEACH, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK ), a specialty pharmaceutical company focused on treatments for gastrointestinal diseases, announced today that the Company will [...]

Skyline Medical Inc. Expands International Presence by Signing Distribution Agreements in Canada and Switzerland

07/11/2017 - 14:30

MINNEAPOLIS, Nov. 07, 2017 (GLOBE NEWSWIRE) -- Skyline Medical Inc . (NASDAQ: SKLN ) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY® System for automated, direct-to-drain medical fluid disposal, [...]

Bellerophon Provides Business Update and Reports Third Quarter 2017 Financial Results

07/11/2017 - 14:30

WARREN, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH ), a clinical-stage biotherapeutics company, today provided a business update and reported financial results for the third [...]

Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019

07/11/2017 - 14:19

IRVINE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA ) today announced that it has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea. Celtis has changed its name [...]

ZIVO Bioscience, Inc. Annual Shareholder Meeting and Conference Call Slated for November 8, 2017 in Detroit, Michigan

07/11/2017 - 14:17

KEEGO HARBOR, Mich., Nov. 07, 2017 (GLOBE NEWSWIRE) -- ZIVO Bioscience, Inc., (OTCQB:ZIVO) a Michigan-based biotech firm, invites shareholders, analysts and partners to its annual shareholder meeting on Wednesday, [...]

Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update

07/11/2017 - 14:15

All 52 weeks of infusions and 100% of the doses have been administered in the NASH Cirrhosis, NASH-CX Phase 2b Clinical Trial Top Line Results of NASH-CX Phase 2b Clinical Trial Expected to be announced in early [...]

Genocea Presents New Data Demonstrating the Power and Versatility of its ATLAS™ Antigen Identification Platform at SITC 2017

07/11/2017 - 14:05

- ATLAS continues to demonstrate superiority to in silico methods of neoantigen identification in multiple tumor types - - ATLAS also identifies unique tumor-associated antigen response signatures in patients with lung [...]

Novan Announces Plan to Complete Development of SB204 Acne Candidate via Third Party Funding and Execution

07/11/2017 - 14:05

MORRISVILLE, N.C., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ: NOVN ) today announced that it has agreed in principle to a business structure that would enable further development [...]

Celldex Reports Third Quarter 2017 Results

07/11/2017 - 14:01

HAMPTON, N.J., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ: CLDX ) today reported business and financial highlights for the third quarter ended September 30, 2017. "In late August, we completed [...]

Initial Results from Phase 2 Study of CB-839 in Combination with Opdivo® (nivolumab) to be Presented at the Society for Immunotherapy of Cancer Meeting

07/11/2017 - 14:01

Achieved confirmed responses in melanoma patients progressing on PD-1/PD-L1 therapy Expanding Bristol-Myers Squibb clinical collaboration SOUTH SAN FRANCISCO, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Calithera [...]

HempAmericana Provides Critical Shareholder Update

07/11/2017 - 14:00

NEW YORK, Nov. 07, 2017 (GLOBE NEWSWIRE) -- HempAmericana, Inc. (OTC:HMPQ) (the “Company”) is excited to provide a critical shareholder update as the Company continues to ramp operations at its Portland, Maine facility [...]